当前位置:首页 - 行情中心 - 古汉医药(000590) - 财务分析 - 现金流量表

古汉医药

(000590)

  

流通市值:24.99亿  总市值:25.00亿
流通股本:2.39亿   总股本:2.39亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金59,106,922.59383,741,332.37258,105,478.45173,900,130.42
  收到的税费返还-556,885.95--
  收到其他与经营活动有关的现金2,554,076.4618,946,102.0371,494,153.9569,750,067.96
  经营活动现金流入小计61,660,999.05403,244,320.35329,599,632.4243,650,198.38
  购买商品、接受劳务支付的现金23,433,262.75146,016,342.88112,486,788.0971,094,983.71
  支付给职工以及为职工支付的现金45,567,563.22133,398,738.88105,089,944.6477,030,515.16
  支付的各项税费7,531,911.0746,870,044.3335,904,790.9230,613,272.85
  支付其他与经营活动有关的现金8,969,182.5848,001,972.2342,986,380.8633,961,206.55
  经营活动现金流出小计85,501,919.62374,287,098.32296,467,904.51212,699,978.27
  经营活动产生的现金流量净额-23,840,920.5728,957,222.0333,131,727.8930,950,220.11
二、投资活动产生的现金流量:
  收回投资收到的现金-254,000,000168,000,000135,000,000
  取得投资收益收到的现金35,881.64556,188.87355,929.69299,874.9
  处置固定资产、无形资产和其他长期资产收回的现金净额2,341,700126,069126,06922,000
  收到的其他与投资活动有关的现金252,336.9859,747,663.01--
  投资活动现金流入小计2,629,918.62314,429,920.88168,481,998.69135,321,874.9
  购建固定资产、无形资产和其他长期资产支付的现金9,677,260.6848,807,066.0232,333,049.4527,300,778.75
  投资支付的现金43,000,000254,000,000201,000,000135,000,000
  投资活动现金流出小计52,677,260.68302,807,066.02233,333,049.45162,300,778.75
  投资活动产生的现金流量净额-50,047,342.0611,622,854.86-64,851,050.76-26,978,903.85
三、筹资活动产生的现金流量:
  取得借款收到的现金-48,680,830.3646,899,788.7742,830,821.08
  收到其他与筹资活动有关的现金-6,000,0005,000,0005,000,000
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-54,680,830.3651,899,788.7747,830,821.08
  偿还债务支付的现金-71,904,801.2835,000,0005,000,000
  分配股利、利润或偿付利息支付的现金743,351.373,780,155.722,848,669.911,781,417.39
  其中:子公司支付给少数股东的股利、利润269,684.7427,471.63317,471.63-
  支付其他与筹资活动有关的现金641,937.2410,164,214.661,922,618.041,513,351.58
  筹资活动现金流出小计1,385,288.6185,849,171.6639,771,287.958,294,768.97
  筹资活动产生的现金流量净额-1,385,288.61-31,168,341.312,128,500.8239,536,052.11
五、现金及现金等价物净增加额-75,273,551.249,411,735.59-19,590,822.0543,507,368.37
  加:期初现金及现金等价物余额170,377,818.18160,588,687.75160,588,687.75160,588,687.75
  期末现金及现金等价物余额95,104,266.94170,000,423.34140,997,865.7204,096,056.12
补充资料:
  净利润--50,074,553.84--17,263,541.22
  资产减值准备-32,796,563.86-640.48
  固定资产和投资性房地产折旧-22,733,192.81-11,304,627.01
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-22,733,192.81-11,304,627.01
  无形资产摊销-6,616,198.82-3,293,234.28
  长期待摊费用摊销-1,666,086.17-807,362.4
  处置固定资产、无形资产和其他长期资产的损失--2,422,610.35--3,444,349.77
  固定资产报废损失-17,700.82-845.53
  财务费用-3,388,277.13-1,907,967.66
  投资损失--778,142.82--36,284.33
  递延所得税--6,060,201.94--3,787,940.55
  其中:递延所得税资产减少--6,720,606.07--3,553,823.96
    递延所得税负债增加-660,404.13--234,116.59
  存货的减少-14,460,673.19--762,918.77
  经营性应收项目的减少-38,524,925.12-55,866,115.02
  经营性应付项目的增加--34,317,599.45--11,814,123.51
  其他--377,394.84--6,537,613.08
  现金的期末余额-170,000,423.34-204,096,056.12
  减:现金的期初余额-160,588,687.75-160,588,687.75
  现金及现金等价物的净增加额-9,411,735.59-43,507,368.37
公告日期2026-04-282026-03-312025-10-302025-08-27
审计意见(境内)标准无保留意见
TOP↑